Pharmacokinetics and lung distribution of macrolide antibiotics in sepsis model rats

References

• Bishai W. (2002). The in vivo-in vitro paradox in pneumococcal respiratory tract infections. J Antimicrob Chemother 49:433–6.
   PubMed Web of Science ®Google Scholar
• Blot SI, Rodriguez A, Solé-Violán J, et al. (2007). Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia. Crit Care Med 35:2509–14.
   PubMed Web of Science ®Google Scholar
• Buyck JM, Plésiat P, Traore H, et al. (2012). Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. Clin Infect Dis 55:534–42.
   PubMed Web of Science ®Google Scholar
• Davey PG. (1991). The pharmacokinetics of clarithromycin andits 14-OH metabolite. J Hosp Infect 19:29–37.
   PubMed Web of Science ®Google Scholar
• Disse B, Gundert-Remy U, Weber E, et al. (1986). Pharmacokinetics of erythromycin in patients with different degrees of renal impairment. Int J Clin Pharmacol Ther Toxicol 24:460–4.
   PubMedGoogle Scholar
• Filist M, Buś-Kwaśnik K, Ksycińska H, et al. (2014). Simplified LC-MS/MS method enabling the determination of azithromycin in human plasma after a low 100mg dose administration. J Pharm Biomed Anal 100:184–9.
   PubMed Web of Science ®Google Scholar
• Gladue RP, Bright GM, Isaacson RE, et al. (1989). In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 33:277–82.
   PubMed Web of Science ®Google Scholar
• Hanada E, Ohtani H, Kotaki H, et al. (1999). Pharmacodynamic analysis of the electrocardiographic interaction between disopyramide and erythromycin in rats. J Pharm Sci 88:234–40.
   PubMed Web of Science ®Google Scholar
• Hand WL, Hand DL. (2001). Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes. Int J Antimicrob Agents 18:419–25.
   PubMed Web of Science ®Google Scholar
• Homma T, Hori T, Ohshiro M, et al. (2010). In vitro pharmacokinetic and pharmacodynamic evaluation of S-013420 against Haemophilus influenzae and Streptococcus pneumoniae. Antimicrob Agents Chemother 54:4300–5.
   PubMed Web of Science ®Google Scholar
• Höffler D, Koeppe P, Paeske B. (1995). Pharmacokinetics of azithromycin in normal and impaired renal function. Infection 23:356–61.
   PubMed Web of Science ®Google Scholar
• Jacobs MR. (2001). Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect 7:589–96.
   PubMed Web of Science ®Google Scholar
• Kim YC, Lee JH, Kim SH, et al. (2005). Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus. Antimicrob Agents Chemother 49:2528–32.
   PubMed Web of Science ®Google Scholar
• Kobuchi S, Fujita A, Ito Y, et al. (2017). Clinical and experimental studies on pharmacokinetics of azithromycin in patients with sepsis. Jpn J Ther Drug Monit 34:119–25.
   Google Scholar
• Kobuchi S, Aoki M, Inoue C, et al. (2016). Transport of azithromycin into extravascular space in rats. Antimicrob Agents Chemother 60:6823–7.
   PubMed Web of Science ®Google Scholar
• Kohno S, Tateda K, Kadota J, et al. (2014). Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia. J Infect Chemother 20:199–207.
   PubMed Web of Science ®Google Scholar
• Kumar A, Roberts D, Wood KE, et al. (2006). Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–96.
   PubMed Web of Science ®Google Scholar
• Lee AK, Lee JH, Kwon JW, et al. (2004). Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate. Biopharm Drug Dispos 25:273–82.
   PubMed Web of Science ®Google Scholar
• Lees P, Illambas J, Potter TJ, et al. (2017). A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida. J Vet Pharmacol Ther 40:419–28.
   PubMed Web of Science ®Google Scholar
• Lemaire S, Tulkens PM, Van Bambeke F. (2010). Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: studies with macrophages and polymorphonuclear neutrophils. Antimicrob Agents Chemother 54:2540–8.
   PubMed Web of Science ®Google Scholar
• Matzneller P, Krasniqi S, Kinzig M, et al. (2013). Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy. Antimicrob Agents Chemother 57:1736–42.
   PubMed Web of Science ®Google Scholar
• McDonald PJ, Pruul H. (1991). Phagocyte uptake and transport of azithromycin. Eur J Clin Microbiol Infect Dis 10:828–33.
   PubMed Web of Science ®Google Scholar
• Müller M, Dela Peña A, Derendorf H. (2004). Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob Agents Chemother 48:1441–53.
   PubMed Web of Science ®Google Scholar
• Nagai K, Kimura O, Domon H, et al. (2019). Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children with acute otitis media in Japan from 2014 to 2017. J Infect Chemother 25:229–32.
   PubMed Web of Science ®Google Scholar
• Olguner CG, Koca U, Altekin E, et al. (2013). Ischemic preconditioning attenuates lipid peroxidation and apoptosis in the cecal ligation and puncture model of sepsis. Exp Ther Med 5:1581–8.
   PubMed Web of Science ®Google Scholar
• Renard C, Vanderhaeghe HJ, Claes PJ, et al. (1987). Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrob Agents Chemother 31:410–6.
   PubMed Web of Science ®Google Scholar
• Ritter C, Andrades M, Frota Júnior ML, et al. (2003). Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med 29:1782–9.
   PubMed Web of Science ®Google Scholar
• Rodvold KA. (1999). Clinical pharmacokinetics of clarithromycin. Clin Pharmacokinet 37:385–98.
   PubMed Web of Science ®Google Scholar
• Senta I, Krizman-Matasic I, Terzic S, et al. (2017). Comprehensive determination of macrolide antibiotics, their synthesis intermediates and transformation products in wastewater effluents and ambient waters by liquid chromatography-tandem mass spectrometry. J Chromatogr A 1509:60–68.
   PubMed Web of Science ®Google Scholar
• Togami K, Chono S, Morimoto K. (2011). Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages. Biopharm Drug Dispos 32:389–97.
   PubMed Web of Science ®Google Scholar
• Toutain PL, Potter T, Pelligand L, et al. (2017). Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf. J Vet Pharmacol Ther 40:16–27.
   PubMed Web of Science ®Google Scholar
• Yanagihara K, Izumikawa K, Higa F, et al. (2009). Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection. Intern Med 48:527–35.
   PubMed Web of Science ®Google Scholar
• Zhou YF, Peng HM, Bu MX, et al. (2017). Pharmacodynamic evaluation and PK/PD-based dose prediction of tulathromycin: a potential new indication for Streptococcus suis infection. Front Pharmacol 8:684.
   PubMed Web of Science ®Google Scholar